We use cookies, just to track visits to our website, we store no personal details.
Learn More
Accept
Essential Medicines & Vaccines
Admin Home
User Management
My Profile
Regional Users
Countrywide Users
Setup
Organisations
Locations
Manufacturers
Health Facilities
Therapeutic Areas
Medicine Class
Generic Names
Dosage Strength
Dosage Form
Package Size
Funding Source
Regional Dashboards
Health Facilities
Registered Premises
Local Manufacturers
Registered Products
Pharmacovigilance
Good Manufacturing Practices
Quality Control Labs
Regional Data
Registered Premises
Local Manufacturers
Registered Products
Good Manufacturing Practices
Quality Control Labs
Product Stocks
Country Profile
Stock Summary
Stock Status
Stock Pipeline
Inventory Control
Stockout Trend
Shipment Reports
Content Manager
News
Upcoming Event
Alerts
Photo Gallery
Video Gallery
Notifications
Document Manager
Guidelines & Manuals
SOPs & Templates
Expression of Interests
Publication
Library
Feedbacks
Profile
Change Password
Messages
Logout
Lang
English
French
Portuguese
Back to List
WAHO Guideline on Good Pharmacovigilance Practice
Author:
WAHO
Category:
Clinical Trials, Pharmacovigilance and Medicines Safety
Language:
English
Description
This Guideline is hereby made by WAHO with references from Good Pharmacovigilance guidelines Nigeria, FDA Ghana, Pharmacy Board of Sierra Leone, MCC South African, ICH and WHO to define the general norms and scientific principles and to set applicable standards for the conduct, performance and control of pharmacovigilance activities in West Africa.
Abstract
underlying objectives of this guideline are to: • harmonize the requirement for reporting adverse reactions in humans arising from the use of Authorized medicinal products within or outside the terms of marketing Authorization; • promote the safe and effective use of medicine, in particular through providing timely information about the safety of medicine to patients, healthcare professionals, marketing Authorization holder and the public. • contribute to the protection of patients’ and public health.
Download PDF